The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| RVP | +27.34% | -91.85% | -39.42% | -94% |
| S&P | +12.66% | +85.37% | +13.13% | +441% |
Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.
Their products are never going out of style, and their valuations are attractive.
The company's been awarded a multimillion-dollar government COVID-19 contract to expand production of needles and syringes.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $10.09M | -2.5% |
| Gross Profit | $1.69M | 11483.6% |
| Gross Margin | 16.72% | 16.9% |
| Market Cap | $25.21M | 9.3% |
| Market Cap / Employee | $0.11M | 0.0% |
| Employees | 227 | 50.3% |
| Net Income | $0.37M | 119.3% |
| EBITDA | -$1.79M | 44.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $3.44M | -12.1% |
| Accounts Receivable | $8.44M | -2.7% |
| Inventory | 20.4 | -4.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.62M | -36.8% |
| Short Term Debt | $0.37M | 10.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -4.24% | 5.0% |
| Return On Invested Capital | 17.79% | -4.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.35M | 79.3% |
| Operating Free Cash Flow | -$1.26M | 78.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.25 | 0.24 | 0.25 | 0.33 | 22.17% |
| Price to Sales | 0.62 | 0.62 | 0.50 | 0.67 | 10.39% |
| Price to Tangible Book Value | 0.25 | 0.24 | 0.25 | 0.33 | 22.17% |
| Price to Free Cash Flow TTM | 19.76 | 9.98 | 7.90 | - | |
| Enterprise Value to EBITDA | 4.22 | 4.75 | 3.87 | 4.21 | 12.30% |
| Free Cash Flow Yield | 5.1% | 10.0% | 12.7% | - | |
| Return on Equity | -12.7% | -25.9% | -10.8% | -8.0% | -53.23% |
| Total Debt | $1.24M | $1.16M | $1.07M | $0.99M | -24.98% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
